Skip to content

Cortical Priming to Optimize Gait Rehabilitation in Stroke: a Renewal

Cortical Priming to Optimize Gait Rehabilitation: Renewal

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04477330
Enrollment
100
Registered
2020-07-20
Start date
2020-09-01
Completion date
2027-08-31
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

tDCS, Walking

Brief summary

Achieving functional ambulation post stroke continues to be a challenge for stroke survivors, clinicians, and researchers. In the effort to enhance outcomes of motor training, cortical priming using brain stimulation has emerged as a promising adjuvant to conventional rehabilitation. This project focuses on the development of a long term gait rehabilitation protocol using brain stimulation to improve walking outcomes in people with stroke. The project will also aim to understand the neural mechanisms that are associated with response to the intervention.

Interventions

OTHERTranscranial direct current stimulation (tDCS)

1 mA tDCS

OTHERAnkle motor training

Visuomotor target tracking task

BEHAVIORALHigh intensity interval speed based treadmill training (HIISTT)

Each treadmill session to include warm-up, high intensity speed-based intervals interleaved with active recovery, and cool down.

Sponsors

University of Illinois at Chicago
Lead SponsorOTHER
University of Maryland, College Park
CollaboratorOTHER
Northwestern University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age greater than 18 years * First ever monohemispheric stroke \> 3 months since onset * Residual hemiparetic gait deficits (e.g. abnormal gait pattern) * Able to walk for 5 minutes at self-paced speed. Handheld assistive device is acceptable. * Walking speed lesser than 1.2 m/s * Lower limb Fugl-Meyer Motor score between 15-30 * At least 5 deg of ankle dorsiflexion necessary to perform the ankle-tracking task

Exclusion criteria

* General

Design outcomes

Primary

MeasureTime frameDescription
Walking speed with 10 meter walk testChange from baseline to immediately after training and baseline to 3 months follow upSelf-selected and fastest gait speed will be measured as the average of 3 trials of the 10-m walk test (10MWT).

Secondary

MeasureTime frameDescription
Community ambulation with wearable sensorsChange from baseline to immediately after training.Daily ambulation will be assessed using an accelerometer.
Serum brain derived neurotrophic growth factor (BDNF)Change from baseline to immediately after training.5 ml of blood will be collected from a vein in the participants' arms
Corticomotor excitability using transcranial magnetic stimulationChange from baseline to immediately after training and baseline to 3 months follow up.Corticomotor excitability of the paretic and non-paretic lower limb muscles such as the tibialis anterior and soleus muscle representations will be measured with single pulse transcranial magnetic stimulation (TMS).
Cognitive function using Mini Mental Screening ExaminationChange from baseline to immediately after training and baseline to 3 months follow up.30-point questionnaire used to capture orientation, attention, memory and language.
Depression using Patient Health Questionnaire-9 (PHQ-9)Change from baseline to immediately after training and baseline to 3 months follow up.The 9-point questionnaire is used to measure degree of depression.
Modified Ashworth ScaleChange from baseline to immediately after training and baseline to 3 months follow up.The modified Ashworth scale is a muscle tone assessment scale used to assess the resistance experienced during passive range of motion,
Quality of Life with EuroQol-5D (EQ-5D)Change from baseline to immediately after training.Quality of life will be measured with the EuroQol-5D (EQ-5D), a questionnaire with questions designed to assess aspects of quality of life.
Walking spatiotemporal characteristics with GAITRite walkwayChange from baseline to immediately after training and baseline to 3 months follow upSpatiotemporal parameters of walking will be assessed using a 7m long pressure sensitive mat (GAITRite walkway).
Motor impairment with Fugl Meyer Lower Extremity ScaleChange from baseline to immediately after training and baseline to 3 months follow upLower extremity impairment will be measured using the Fugl Meyer Lower Extremity Scale (FMLE), a series of tests of movement, reflex activity, coordination/speed, sensation, and range of motion. The maximum score is 34 and a high score indicates less impairment
Walking endurance with 6-minute walk testChange from baseline to immediately after training and baseline to 3 months follow upWalking endurance will be measured using the 6-Minute Walk test. Participants will walk as far as possible within 6 minutes.
Ankle range of motionChange from baseline to immediately after training and baseline to 3 months follow upAnkle range of motion will be measured using a wireless electrogoniometer affixed to the ankle.
Ankle motor controlChange from baseline to immediately after training and baseline to 3 months follow upThe participant will track a computer-generated sinusoidal target with ankle dorsiflexion and plantarflexion in a custom-built ankle-tracking device. Accuracy of tracking the target with ankle motion will be calculated.
Balance with mini Balance Evaluations Systems Test (miniBESTest)Change from baseline to immediately after training and baseline to 3 months follow up.Balance will be tested with the Mini-BESTest, involving 14 different tasks to challenge balance.
Disability with Modified Rankin ScaleChange from baseline to immediately after training and baseline to 3 months follow up.Global disability will be measured with the modified Rankin Scale, a simple 0-6 rating scale.
Aerobic capacityChange from baseline to immediately after training.Cardiopulmonary exercise tests will be performed on a motorized treadmill following an individualized protocol using standard procedures. Measures relating to peak oxygen consumption (VO2 max) will be calculated.

Countries

United States

Contacts

CONTACTSangeetha Madhavan
smadhava@uic.edu3123552517
PRINCIPAL_INVESTIGATORSangeetha Madhavan

University of Illinois at Chicago

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026